• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机对照研究六种许可的三价流感疫苗对血清抗血凝素和抗神经氨酸酶抗体的应答反应。

Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.

机构信息

Departments of Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Vaccine. 2012 Dec 17;31(1):190-5. doi: 10.1016/j.vaccine.2012.10.065. Epub 2012 Oct 26.

DOI:10.1016/j.vaccine.2012.10.065
PMID:23107591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3520601/
Abstract

BACKGROUND

Serum antibody to the hemagglutinin (HA) surface protein of influenza virus induced by influenza vaccination is a correlate of protection against influenza. The neuraminidase (NA) protein is also on the surface of the virus; antibody to it has been shown to impair virus release from infected cells and to reduce the intensity of influenza infections in animal models and in humans challenged with infectious virus. Recently we have shown that NA inhibiting antibody can independently contribute to immunity to naturally-occurring influenza immunity in the presence of antibody to the HA.

PURPOSE

The present study was conducted to evaluate induction of antibody to the NA and the HA by commercially available influenza vaccines.

METHODS

Healthy young adults were vaccinated with one of five commercially available trivalent inactivated vaccines or live influenza vaccine. Frequencies of serum antibody and fold geometric mean titer (GMT) increases four weeks later were measured to each of the three vaccine viruses (A/H1N1, A/H3N2, B) in hemagglutination-inhibition (HAI) and neutralization (neut) assays. Frequency and fold GMT increase in neuraminidase-inhibition (NI) antibody titers were measured to the influenza A viruses (A/H1N1, A/H3N2).

RESULTS

No significant reactogenicity occurred among the vaccinated subjects. The Fluvirin inactivated vaccine induced more anti-HA antibody responses and a higher fold GMT increase than the other inactivated vaccines but there were no major differences in response frequencies or fold GMT increase among the inactivated vaccines. Both the frequency of antibody increase and fold GMT increase were significantly lower for live vaccine than for any inactivated vaccine in HAI and neut assays for all three vaccine viruses. Afluria inactivated vaccine induced more N1 antibody and Fluarix induced more N2 antibody than the other vaccines but all inactivated vaccines induced serum NI antibody. The live vaccine failed to elicit any NI responses for the N2 NA of A/H3N2 virus and frequencies were low for the N1 of A/H1N1 virus.

CONCLUSIONS

Trivalent inactivated influenza vaccines with similar HA dosage induce similar serum anti-HA antibody responses in healthy adults. Current inactivated vaccines all induce serum anti-NA antibody to the N1 and N2 NA proteins but some are better than others for N1 or N2. The live vaccine, Flumist, was a poor inducer of either anti-HA or anti-NA serum antibody compared to inactivated vaccine in the healthy adults. In view of the capacity for contributing to immunity to influenza in humans, developing guidelines for NA content and induction of NA antibody is desirable.

摘要

背景

流感疫苗诱导的针对流感病毒血凝素(HA)表面蛋白的血清抗体是预防流感的相关保护因素。神经氨酸酶(NA)蛋白也存在于病毒表面;已证明针对它的抗体可以破坏感染细胞中病毒的释放,并降低动物模型和感染传染性病毒的人类中流感感染的强度。最近,我们已经证明,在存在针对 HA 的抗体的情况下,NA 抑制抗体可以独立有助于对自然发生的流感免疫的免疫。

目的

本研究旨在评估市售流感疫苗对 NA 和 HA 的诱导作用。

方法

健康的年轻成年人接种了五种市售的三价灭活疫苗或活流感疫苗之一。四周后,通过血凝抑制(HAI)和中和(neut)测定测量针对三种疫苗病毒(A/H1N1、A/H3N2、B)的血清抗体和几何平均滴度(GMT)增加的频率。测量针对流感 A 病毒(A/H1N1、A/H3N2)的神经氨酸酶抑制(NI)抗体滴度的频率和 GMT 增加倍数。

结果

接种疫苗的受试者没有出现明显的不良反应。与其他灭活疫苗相比,Fluvirin 灭活疫苗诱导了更多的抗 HA 抗体反应和更高的 GMT 增加倍数,但在灭活疫苗中,反应频率或 GMT 增加倍数没有明显差异。与任何灭活疫苗相比,活疫苗在 HAI 和 neut 测定中对所有三种疫苗病毒的抗体增加频率和 GMT 增加倍数都显著降低。与其他疫苗相比,Afluria 灭活疫苗诱导了更多的 N1 抗体,Fluarix 诱导了更多的 N2 抗体,但所有灭活疫苗都诱导了血清 NI 抗体。活疫苗未能引起 A/H3N2 病毒 N2 NA 的任何 NI 反应,N1 的频率也很低。

结论

具有相似 HA 剂量的三价灭活流感疫苗在健康成年人中诱导相似的血清抗 HA 抗体反应。目前的灭活疫苗都诱导针对 N1 和 N2 NA 蛋白的血清抗 NA 抗体,但有些比其他的更好用于 N1 或 N2。与灭活疫苗相比,活疫苗 Flumist 在健康成年人中对抗 HA 或抗 NA 血清抗体的诱导能力较差。鉴于其对人类流感免疫的贡献能力,制定关于 NA 含量和 NA 抗体诱导的指南是可取的。

相似文献

1
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.随机对照研究六种许可的三价流感疫苗对血清抗血凝素和抗神经氨酸酶抗体的应答反应。
Vaccine. 2012 Dec 17;31(1):190-5. doi: 10.1016/j.vaccine.2012.10.065. Epub 2012 Oct 26.
2
Comparison of neuraminidase inhibiting antibody responses elicited by egg- and cell-derived influenza vaccines.鸡蛋源性和细胞源性流感疫苗引发的神经氨酸酶抑制抗体反应的比较。
Vaccine. 2025 Feb 6;46:126669. doi: 10.1016/j.vaccine.2024.126669. Epub 2025 Jan 5.
3
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.高剂量流感疫苗在老年受试者中诱导的神经氨酸酶抗体显著多于标准疫苗。
Vaccine. 2010 Feb 25;28(9):2076-9. doi: 10.1016/j.vaccine.2009.12.041. Epub 2009 Dec 29.
4
Stability of neuraminidase in inactivated influenza vaccines.神经氨酸酶在灭活流感疫苗中的稳定性。
Vaccine. 2014 Apr 17;32(19):2225-30. doi: 10.1016/j.vaccine.2014.01.078. Epub 2014 Mar 6.
5
Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.对部分免疫的幼儿接种三价灭活流感疫苗。
Pediatrics. 2006 Sep;118(3):e579-85. doi: 10.1542/peds.2006-0201.
6
Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.灭活H7流感病毒疫苗尽管仅诱导产生低水平的中和抗体,但仍可保护小鼠。
J Virol. 2017 Sep 27;91(20). doi: 10.1128/JVI.01202-17. Print 2017 Oct 15.
7
VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.VaxArray 用于流感疫苗血凝素和神经氨酸酶效力检测。
Vaccine. 2018 May 17;36(21):2937-2945. doi: 10.1016/j.vaccine.2018.04.048. Epub 2018 Apr 23.
8
Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.人体对自然发生的流感的免疫的抗体相关性和预测因素,以及神经氨酸酶抗体的重要性。
J Infect Dis. 2013 Mar 15;207(6):974-81. doi: 10.1093/infdis/jis935. Epub 2013 Jan 10.
9
Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.流感疫苗接种一至两年后针对流感血凝素和神经氨酸酶抗体的持久性
J Infect Dis. 2015 Dec 15;212(12):1914-22. doi: 10.1093/infdis/jiv313. Epub 2015 May 26.
10
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.神经氨酸酶抑制抗体滴度与对同一神经氨酸酶亚型的异源流感病毒株的保护作用相关。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.01006-18. Print 2018 Sep 1.

引用本文的文献

1
Induction of hemagglutinin stalk reactive antibodies by the administration of a live-attenuated influenza virus vaccine in children.在儿童中接种减毒活流感病毒疫苗诱导血凝素茎部反应性抗体。
iScience. 2025 Jun 13;28(7):112893. doi: 10.1016/j.isci.2025.112893. eCollection 2025 Jul 18.
2
Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase.编码血凝素和神经氨酸酶的基于信使核糖核酸的季节性流感疫苗的免疫原性和安全性。
Nat Commun. 2025 Jul 1;16(1):5933. doi: 10.1038/s41467-025-60938-4.
3
Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study.关于神经氨酸酶在传统流感疫苗中作用的专家共识:一项德尔菲研究
BMC Infect Dis. 2025 Jan 11;25(1):53. doi: 10.1186/s12879-024-10277-4.
4
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA.表达一种 mRNA 编码的多种病毒糖蛋白可提高流感疫苗的反应效果。
Nat Commun. 2024 Oct 8;15(1):8712. doi: 10.1038/s41467-024-52940-z.
5
COBRA N2 NA vaccines induce protective immune responses against influenza viral infection.COBRA N2 NA 疫苗可诱导针对流感病毒感染的保护性免疫应答。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2403175. doi: 10.1080/21645515.2024.2403175. Epub 2024 Sep 18.
6
Antibody-independent surface plasmon resonance assays for influenza vaccine quality control.用于流感疫苗质量控制的非抗体表面等离子体共振分析
Appl Microbiol Biotechnol. 2024 Apr 24;108(1):307. doi: 10.1007/s00253-024-13145-y.
7
Anti-neuraminidase immunity in the combat against influenza.抗神经氨酸酶免疫在抗击流感中的作用。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):474-484. doi: 10.1080/14760584.2024.2343689. Epub 2024 Apr 23.
8
Evaluation of Vaccine Immunogenicity-Correlates to Real-World Protection: Influenza.疫苗免疫原性与真实世界保护相关性评估:流感。
Viruses. 2024 Mar 12;16(3):441. doi: 10.3390/v16030441.
9
Targeting neuraminidase: the next frontier for broadly protective influenza vaccines.靶向神经氨酸酶:广谱保护性流感疫苗的下一个前沿。
Trends Immunol. 2024 Jan;45(1):11-19. doi: 10.1016/j.it.2023.11.001. Epub 2023 Dec 15.
10
Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines.季节性灭活流感疫苗免疫后甲型流感病毒神经氨酸酶和血凝素抗体的纵向分析
Vaccines (Basel). 2023 Nov 20;11(11):1731. doi: 10.3390/vaccines11111731.

本文引用的文献

1
An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.一项在健康成年人中使用活减毒 H2N2 流感病毒疫苗的开放性 I 期临床试验。
Influenza Other Respir Viruses. 2013 Jan;7(1):66-73. doi: 10.1111/j.1750-2659.2012.00350.x. Epub 2012 Mar 14.
2
A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies.一种由vero 细胞衍生的全病毒 H5N1 疫苗能有效地诱导神经氨酸酶抑制抗体。
J Infect Dis. 2012 Jan 1;205(1):28-34. doi: 10.1093/infdis/jir711. Epub 2011 Nov 16.
3
The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.三价活减毒流感疫苗和灭活流感疫苗在儿童和成人中的相对疗效。
Influenza Other Respir Viruses. 2011 Mar;5(2):67-75. doi: 10.1111/j.1750-2659.2010.00183.x. Epub 2010 Nov 19.
4
Budding capability of the influenza virus neuraminidase can be modulated by tetherin.流感病毒神经氨酸酶的出芽能力可以被 tetherin 调节。
J Virol. 2011 Mar;85(6):2480-91. doi: 10.1128/JVI.02188-10. Epub 2011 Jan 5.
5
Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner.灭活季节性流感疫苗会使血清中针对 2009 年大流行的甲型流感病毒(H1N1)神经氨酸酶的抗体呈年龄依赖性增加。
J Infect Dis. 2010 Dec 1;202(11):1634-8. doi: 10.1086/657084. Epub 2010 Oct 27.
6
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.预防和控制流感的疫苗:免疫实践咨询委员会(ACIP)的建议,2010 年。
MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62.
7
Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase.仅表达流感神经氨酸酶的人细胞系中病毒样颗粒的形成。
J Gen Virol. 2010 Sep;91(Pt 9):2322-30. doi: 10.1099/vir.0.019935-0. Epub 2010 May 26.
8
A Phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children.一项评价两种三价季节性流感灭活疫苗在美国儿童中免疫原性和安全性的 III 期临床研究
Pediatr Infect Dis J. 2010 Oct;29(10):924-30. doi: 10.1097/INF.0b013e3181e075be.
9
Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.6 个月至 17 岁儿童中减毒活流感疫苗的效力。
Influenza Other Respir Viruses. 2010 May 1;4(3):141-5. doi: 10.1111/j.1750-2659.2009.00124.x.
10
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.高剂量流感疫苗在老年受试者中诱导的神经氨酸酶抗体显著多于标准疫苗。
Vaccine. 2010 Feb 25;28(9):2076-9. doi: 10.1016/j.vaccine.2009.12.041. Epub 2009 Dec 29.